RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+3.6%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$955M
AUM Growth
+$955M
(+8.5%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
94
New
8
Increased
32
Reduced
32
Closed
4
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$13.5M |
| 2 |
Becton Dickinson
BDX
|
$9.44M |
| 3 |
Biogen
BIIB
|
$9.29M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$8.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
$7.92M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$14.9M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$12.2M |
| 3 |
Cigna
CI
|
$11.6M |
| 4 |
Elevance Health
ELV
|
$9.3M |
| 5 |
Pfizer
PFE
|
$8.84M |
Sector Composition
| 1 | Healthcare | 98.85% |
| 2 | Industrials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenet Healthcare
THC
$16.5B
| $15.3M | 1.6% |
344,000
+83,000
| +32% | +$3.68M |
|
27
BioNTech
BNTX
$24.1B
| $13.6M | 1.43% |
99,000
+9,000
| +10% | +$1.24M |
|
28
Apellis Pharmaceuticals
APLS
$3.51B
| $13.3M | 1.39% |
220,000
+10,000
| +5% | +$605K |
|
|
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.3M | 1.39% |
197,067
+7,067
| +4% | +$476K |
|
30
Cooper Companies
COO
$13.3B
| $12.8M | 1.34% |
187,608
+39,608
| +27% | +$2.71M |
|
31
Harmony Biosciences
HRMY
$2.16B
| $12.3M | 1.29% |
237,000
-23,000
| -9% | -$1.2M |
|
32
Intuitive Surgical
ISRG
$158B
| $12.3M | 1.29% |
50,000
-20,000
| -29% | -$4.93M |
|
33
Inspire Medical Systems
INSP
$2.53B
| $12.3M | 1.29% |
63,000
+13,000
| +26% | +$2.53M |
|
34
Abbott
ABT
$230B
| $11.6M | 1.21% |
117,000
-53,000
| -31% | -$5.24M |
|
35
Neurocrine Biosciences
NBIX
$13.5B
| $9.56M | 1% |
83,000
-12,000
| -13% | -$1.38M |
|
36
HCA Healthcare
HCA
$95.4B
| $9.35M | 0.98% |
43,000
+18,000
| +72% | +$3.91M |
|
|
37
Biogen
BIIB
$20.5B
| $9.29M | 0.97% |
+32,782
| New | +$9.29M |
|
38
Privia Health
PRVA
$2.85B
| $9.27M | 0.97% |
277,000
-23,000
| -8% | -$770K |
|
39
Cytokinetics
CYTK
$5.98B
| $9.17M | 0.96% |
210,000
-20,000
| -9% | -$873K |
|
40
Royalty Pharma
RPRX
$15.8B
| $9.1M | 0.95% |
215,000
+65,000
| +43% | +$2.75M |
|
41
Edwards Lifesciences
EW
$47.7B
| $9.05M | 0.95% |
125,000
+80,000
| +178% | +$5.79M |
|
|
ISEE
42
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.73M | 0.91% |
365,000
+115,000
| +46% | +$2.75M |
|
|
RVNC
43
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.66M | 0.91% |
388,000
-62,000
| -14% | -$1.38M |
|
44
Immunocore
IMCR
$1.78B
| $8.57M | 0.9% |
150,000
+10,000
| +7% | +$571K |
|
45
Dynavax Technologies
DVAX
$1.19B
| $8.4M | 0.88% |
733,519
-66,481
| -8% | -$761K |
|
46
Xencor
XNCR
$594M
| $8.23M | 0.86% |
294,076
-5,924
| -2% | -$166K |
|
|
HZNP
47
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.1M | 0.85% |
130,000
-195,299
| -60% | -$12.2M |
|
48
Insulet
PODD
$24.2B
| $7.51M | 0.79% |
+29,000
| New | +$7.51M |
|
49
Esperion Therapeutics
ESPR
$490M
| $7.32M | 0.77% |
900,000
| – | – |
|
|
SILK
50
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $6.83M | 0.72% |
155,000
-20,000
| -11% | -$882K |
|